Algenis
PrivateLast Round
VC Round
Oct 6, 2011
Company Overview
Algenis is a Chilean biotechnology company founded in 2002 that specializes in the research, production, and clinical development of bioactive molecules derived from marine microalgae. The company focuses on developing sodium channel blocking molecules for therapeutic use in multiple diseases. Its primary drug candidate, Gonyautoxin, is being developed to treat conditions such as Chronic Anal Fissures and Chronic Tension-type headaches. Algenis is actively conducting Phase I clinical studies under the supervision of the U.S. Food and Drug Administration (FDA). The company's technology is based on using paralytic shellfish poison (PSP) type molecules as potent neurotoxins that block the signaling pathways of excitable cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Algenis Comps
Public and private peers based on sector, stage, and business model.
Algenis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 6, 2011 |
Algenis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aurus Capital | VC Round |
Algenis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Algenis's valuation, stock price, and market status.
